Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies.

about

Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies.

Item

http://www.wikidata.org/entity/Q39347577

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Role of PET to evaluate corona ...... non-ischemic cardiomyopathies.

@en

Role of PET to evaluate corona ...... non-ischemic cardiomyopathies.

@nl

type

Item

label

Role of PET to evaluate corona ...... non-ischemic cardiomyopathies.

@en

Role of PET to evaluate corona ...... non-ischemic cardiomyopathies.

@nl

prefLabel

Role of PET to evaluate corona ...... non-ischemic cardiomyopathies.

@en

Role of PET to evaluate corona ...... non-ischemic cardiomyopathies.

@nl

P1476

Role of PET to evaluate corona ...... non-ischemic cardiomyopathies

@en

P2093

Marcelo F Di Carli

http://www.w3.org/2001/XMLSchema#string

Paco E Bravo

http://www.w3.org/2001/XMLSchema#string

Sharmila Dorbala

http://www.w3.org/2001/XMLSchema#string

P2860

Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy

Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy.

Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.

Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis.

Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.

Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins

Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A

The heart in Anderson-Fabry disease and other lysosomal storage disorders.

P2888

s10741-017-9628-1

P304

455-464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10741-017-9628-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28577279

http://www.w3.org/2001/XMLSchema#string

P932

6214157

http://www.w3.org/2001/XMLSchema#string